About us

We promise to open new horizons in the biomedical field.

Company History

With years of clinical experience, Astrogen is exploring new horizons in innovative
new drug development field at an unprecedented speed.

2021 highlights
  • December
    • Received Presidential Award for Merit of Promoting Venture Start-up
    • Acquired Family-Friendly Company Certification
  • November
    • The R&D center received the certificate of Excellent Corporation R&D Center in the Korea Industrial Technology Association (KOITA)
  • September
    • Selected as Pre-Star company in Daegu
  • July
    • Signed MOU with CK Regeon Inc. for research collaboration
  • February
    • Announced commencement of Phase 2 clinical study of AST-001
2020 highlights
  • December
    • 13 billion Won (KRW) rights issue (Series B)
    • Daegu Start-up Awards The grand prize
    • Awarded by the Minister of Trade, Industry, and Energy
  • November
    • Selected as one of the innovative companies of "the 1000 National Representatives of Innovative Companies" by Financial Services
  • July
    • AST-001 clinical test phase 2 IND approval
  • June
    • Selected as one of the K-Unicorn companies by the Ministry of SMEs and Startups
  • May
    • New Astrogen Office Building Completion
  • March
    • 1 patent registration
    • AST-001 clinical test phase 1 IND, IRB approval
  • January
    • 1 PCT (International patent application) filed
2019 highlights
  • December
    • New construction of the research institute and office building
  • November
    • Selected as a frontier venture company
    • Kibo A + Members selection
  • August
    • 5 billion Won (KRW) rights issue (Series A)
  • May
    • Approval for moving in the Daegu Gyeongbuk Advanced Medical Complex
  • March
    • Opened Seoul office
  • February
    • 2 patent registrations
    • 1 PCT (International patent application) filed
2018 highlights
  • December
    • Acquisition of the Kyunghee University Technology license agreement
  • September
    • 1 Patent application
  • August
    • 1.9 billion Won (KRW) rights issue (SEED)
    • 1 Patent application
  • January
    • Approval of an affiliated research institute
2017 highlights
  • October
    • Opened a 2nd office and logistics warehouse
    • Neurodevelopmental disorder improvement food development
  • August
    • Venture company certification
  • July
    • Astrogen Ltd. Incorporation